Veterinary Diagnostic Imaging Market

Executive Summary

Veterinary Diagnostic Imaging Market was valued at US $1.71 billion in 2021 and is projected to grow at 6.78% CAGR over the forecast period to reach US $2.53 billion by 2027. Veterinary Diagnostic Imaging Market represented US $0.21 billion opportunity over 2019-2021 and estimated to create US $0.82 billion opportunity in 2027 over 2021.

Veterinary Diagnostic Imaging from Consainsights analyses the Veterinary Diagnostic Imaging Market in the Life Sciences industry over the forecast period to 2027.

Veterinary Diagnostic Imaging research report from Consainsights outlines the detailed strategic analysis, trends, market opportunities, growth prospects, industry and market challenges and sustainable solutions to sustain in the competitive environment.

Veterinary Diagnostic Imaging segmentation includes Equipment, Application, Animal Type and Geography.

Based on the Equipment, the Veterinary Diagnostic Imaging analysis covers Radiography (X-ray) Systems, Ultrasound Imaging Systems, Computed Tomography Imaging Systems, Magnetic Resonance Imaging Systems, Video Endoscopy Imaging Systems, Other Equipment.

In Equipment segment, Radiography (X-ray) Systems segment has highest cagr growth of 6.00%.

Based on the Application, the Veterinary Diagnostic Imaging analysis covers Cardiology, Oncology, Neurology, Orthopedics, Other Applications.

In Application segment, Cardiology segment has highest cagr growth of 6.00%.

Based on the Animal Type, the Veterinary Diagnostic Imaging analysis covers Small Animals, Large Animals.

In Animal Type segment, Small Animals segment has highest cagr growth of 6.00%.

Based on the region, the Veterinary Diagnostic Imaging analysis covers North America, Europe, Asia-Pacific, Middle-East & Africa, Latin America.

Key companies operating in the market include Canon Medical Systems Corporation, Carestream Health, Epica Animal Health, Esaote SPA, Fujifilm Holdings, Hallmarq Veterinary Imaging, IDEXX Laboratories Inc., IMV Imaging, Sound and so on. This report covers the detailed analysis of the company profiles such as business segments, product portfolio, key brand insights and growth strategies adopted, company SWOT and Strategy analysis along with the financial analysis and analyst insights on the key companies operating in this market.

Market Overview

Definition & Scope

The base currency considered was the US Dollar (USD). Conversion of other currencies to USD was considered on the basis of the average exchange rate for the respective review-period years. The exchange rate conversion for forecast period was determined according to the base year’s conversion rates.

The base year was identified based on the availability of annual reports and secondary information. The base year considered for this study is 2027.

The review period considered for this study is from 2018-2027. The CAGR is for the forecast period, 2022-2027.

Market size estimations for the forecast years were in real terms. Inflation is not part of the pricing, and the average selling price (ASP) was kept constant throughout the forecast period for each country.

Distribution of primary interviews conducted was based on the regional share of the market and the presence of key players in each region.

As a result of data triangulation through multiple methodologies and approaches, the weighted averages of resulting estimates were considered to be the final values.

Currency, Year & Forecast

The currency used in this report is USD, with the market size indicated in terms of USD million/billion.

For companies reporting their revenues in USD, the revenues were taken from their respective annual reports/SEC filings.

For companies reporting their revenues in other currencies, the average annual currency conversion rates were used for a particular year to convert the value to USD Market Definition.

Equipment

Introduction

In 2021, Radiography (X-ray) Systems segment has the highest revenue of US $0.64 billion and is expected to grow at CAGR of 6.00% by 2027 Radiography (X-ray) Systems segment has highest cagr growth of 6.00%.

Radiography (X-ray) Systems

Radiography (X-ray) Systems segment was valued at US $0.56 billion in 2019 and is projected to grow at 6.00% CAGR over the forecast period to reach US $0.94 billion by 2027. Radiography (X-ray) Systems segment represented US $0.08 billion opportunity over 2019-2021 and estimated to create US $0.31 billion opportunity in 2027 over 2021.

Ultrasound Imaging Systems

Ultrasound Imaging Systems segment was valued at US $0.33 billion in 2019 and is projected to grow at 6.00% CAGR over the forecast period to reach US $0.55 billion by 2027. Ultrasound Imaging Systems segment represented US $0.05 billion opportunity over 2019-2021 and estimated to create US $0.18 billion opportunity in 2027 over 2021.

Computed Tomography Imaging Systems

Computed Tomography Imaging Systems segment was valued at US $0.23 billion in 2019 and is projected to grow at 6.00% CAGR over the forecast period to reach US $0.40 billion by 2027. Computed Tomography Imaging Systems segment represented US $0.03 billion opportunity over 2019-2021 and estimated to create US $0.13 billion opportunity in 2027 over 2021.

Magnetic Resonance Imaging Systems

Magnetic Resonance Imaging Systems segment was valued at US $0.18 billion in 2019 and is projected to grow at 6.00% CAGR over the forecast period to reach US $0.31 billion by 2027. Magnetic Resonance Imaging Systems segment represented US $0.03 billion opportunity over 2019-2021 and estimated to create US $0.10 billion opportunity in 2027 over 2021.

Video Endoscopy Imaging Systems

Video Endoscopy Imaging Systems segment was valued at US $0.11 billion in 2019 and is projected to grow at 6.00% CAGR over the forecast period to reach US $0.19 billion by 2027. Video Endoscopy Imaging Systems segment represented US $0.02 billion opportunity over 2019-2021 and estimated to create US $0.06 billion opportunity in 2027 over 2021.

Other Equipment

Other Equipment segment was valued at US $0.08 billion in 2019 and is projected to grow at 6.00% CAGR over the forecast period to reach US $0.14 billion by 2027. Other Equipment segment represented US $0.01 billion opportunity over 2019-2021 and estimated to create US $0.05 billion opportunity in 2027 over 2021.

Application

Introduction

In 2021, Cardiology segment has the highest revenue of US $0.74 billion and is expected to grow at CAGR of 6.00% by 2027 Cardiology segment has highest cagr growth of 6.00%.

Cardiology

Cardiology segment was valued at US $0.65 billion in 2019 and is projected to grow at 6.00% CAGR over the forecast period to reach US $1.09 billion by 2027. Cardiology segment represented US $0.09 billion opportunity over 2019-2021 and estimated to create US $0.35 billion opportunity in 2027 over 2021.

Oncology

Oncology segment was valued at US $0.39 billion in 2019 and is projected to grow at 6.00% CAGR over the forecast period to reach US $0.66 billion by 2027. Oncology segment represented US $0.05 billion opportunity over 2019-2021 and estimated to create US $0.21 billion opportunity in 2027 over 2021.

Neurology

Neurology segment was valued at US $0.25 billion in 2019 and is projected to grow at 6.00% CAGR over the forecast period to reach US $0.42 billion by 2027. Neurology segment represented US $0.03 billion opportunity over 2019-2021 and estimated to create US $0.14 billion opportunity in 2027 over 2021.

Orthopedics

Orthopedics segment was valued at US $0.12 billion in 2019 and is projected to grow at 6.00% CAGR over the forecast period to reach US $0.21 billion by 2027. Orthopedics segment represented US $0.02 billion opportunity over 2019-2021 and estimated to create US $0.07 billion opportunity in 2027 over 2021.

Other Applications

Other Applications segment was valued at US $0.09 billion in 2019 and is projected to grow at 6.00% CAGR over the forecast period to reach US $0.15 billion by 2027. Other Applications segment represented US $0.01 billion opportunity over 2019-2021 and estimated to create US $0.05 billion opportunity in 2027 over 2021.

Animal Type

Introduction

In 2021, Small Animals segment has the highest revenue of US $1.13 billion and is expected to grow at CAGR of 6.00% by 2027 Small Animals segment has highest cagr growth of 6.00%.

Small Animals

Small Animals segment was valued at US $0.99 billion in 2019 and is projected to grow at 6.00% CAGR over the forecast period to reach US $1.68 billion by 2027. Small Animals segment represented US $0.14 billion opportunity over 2019-2021 and estimated to create US $0.55 billion opportunity in 2027 over 2021.

Large Animals

Large Animals segment was valued at US $0.51 billion in 2019 and is projected to grow at 6.00% CAGR over the forecast period to reach US $0.86 billion by 2027. Large Animals segment represented US $0.07 billion opportunity over 2019-2021 and estimated to create US $0.28 billion opportunity in 2027 over 2021.